文献速递炎症性肠病

系统综述与荟萃分析:维生素D状态与成人炎症性肠病临床结局的关联

Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2019-10-24

结果显示低25(OH)D状态与疾病活动度、黏膜炎症、低生活质量评分及未来临床复发风险升高相关。

要点

  • 低25(OH)D状态与IBD疾病活动度风险升高相关(OR 1.53)。
  • 低25(OH)D状态与黏膜炎症、低生活质量及未来临床复发风险升高相关。
  • 克罗恩病和溃疡性结肠炎亚组中低维生素D状态均与不良结局相关。

核心结论

  • 低25(OH)D状态是IBD疾病活动的生物标志物,也是不良临床结局的预测因素。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Embase、Scopus和Web of Science自建库至2018年2月的观察性研究。
  • 采用随机效应模型汇总OR进行分析。

主要发现

  • 在IBD患者中,低25(OH)D状态与疾病活动度风险升高相关(OR 1.53,95%CI 1.32-1.77,I2=0%)。
  • 低25(OH)D状态与黏膜炎症风险升高相关(OR 1.25,95%CI 1.06-1.47,I2=0%)。
  • 低25(OH)D状态与低生活质量评分风险升高相关(OR 1.30,95%CI 1.06-1.60,I2=0%)。
  • 低25(OH)D状态与未来临床复发风险升高相关(OR 1.23,95%CI 1.03-1.47,I2=0%)。
  • 克罗恩病亚组中,低维生素D状态与疾病活动度(OR 1.66,95%CI 1.36-2.03)、黏膜炎症(OR 1.39,95%CI 1.03-1.85)、临床复发(OR 1.35,95%CI 1.14-1.59)及低生活质量评分(OR 1.25,95%CI 1.04-1.50)相关。

关键数值与推荐

  • IBD患者低25(OH)D状态与疾病活动度相关:OR 1.53(95%CI 1.32-1.77,I2=0%)。
  • IBD患者低25(OH)D状态与黏膜炎症相关:OR 1.25(95%CI 1.06-1.47,I2=0%)。
  • IBD患者低25(OH)D状态与低生活质量评分相关:OR 1.30(95%CI 1.06-1.60,I2=0%)。
  • IBD患者低25(OH)D状态与未来临床复发相关:OR 1.23(95%CI 1.03-1.47,I2=0%)。
  • 溃疡性结肠炎亚组中,低维生素D状态与疾病活动度(OR 1.47,95%CI 1.03-2.09)及临床复发(OR 1.20,95%CI 1.01-1.43)相关。

临床怎么用

  • 对IBD患者可监测25(OH)D水平,低水平提示疾病活动及不良结局风险较高。
  • 低25(OH)D状态可作为IBD疾病活动度和未来复发的生物标志物参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitamin D deficiency is highly prevalent among patients with IBD, however, data on its association with clinical outcomes are conflicting. AIM: To perform a systematic review and meta-analysis to explore the association of low vitamin D status with clinical outcomes in patients with IBD. METHODS: We searched PubMed, Embase, Scopus and Web of Science from inception to February 2018 for observational studies evaluating the association of low 25(OH)D status on IBD disease activity, mucosal inflammation, clinical relapse and quality of life. Odds ratios (ORs) were pooled and analysed using a random effects model. RESULTS: Twenty-seven studies were eligible for inclusion comprising 8316 IBD patients (3115 ulcerative colitis, 5201 Crohn's disease). Among IBD patients, low 25(OH)D status was associated with increased odds of disease activity (OR 1.53, 95% CI 1.32-1.77, I2 = 0%), mucosal inflammation (OR 1.25, 95% CI 1.06-1.47, I2 = 0%), low quality of life (QOL) scores (OR 1.30, 95% CI 1.06-1.60, I2 = 0%) and future clinical relapse (OR 1.23, 95% CI 1.03-1.47, I2 = 0%). In subgroup analysis, low vitamin D status was associated with Crohn's disease activity (OR 1.66, 95% CI 1.36-2.03, I2 = 0%), mucosal inflammation (OR 1.39, 95% CI 1.03-1.85, I2 = 0%), clinical relapse (OR 1.35, 95% CI 1.14-1.59, I2 = 0%), and low QOL scores (OR 1.25, 95% CI 1.04-1.50, I2 = 0%) and ulcerative colitis disease activity (OR 1.47, 95% CI 1.03-2.09, I2 = 0%) and clinical relapse (OR 1.20, 95% 1.01-1.43, I2 = 0%). CONCLUSIONS: Low 25(OH)D status is a biomarker for disease activity and predictor of poor clinical outcomes in IBD patients.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Gubatan J, Chou ND, Nielsen OH, et al. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019. PMID: 31647134. doi:10.1111/apt.15506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。